
Opinion|Videos|November 22, 2024
Final Thoughts
Key Takeaways
The panel discussion concludes with final thoughts on the future landscape of newly diagnosed multiple myeloma.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Final EMBARK Data Show “Almost Unprecedented” Reduction in Risk of Death With Enzalutamide Plus ADT in Biochemically Recurrent Prostate Cancer
2
Dato-DXd Doubles Response Rates and Extends Survival in First-Line Metastatic TNBC
3
From Mutation to Medicine: Targeted Therapies in Lung Cancer
4
Addressing Drug Resistance in Lung Cancer
5